Canadian Agency for Drugs and Technologies in Health Appoints Public Member to its Health Technology Expert Review Panel

OTTAWA — The Canadian Agency for Drugs and Technologies in Health (CADTH) today announced the appointment of a Public Member to its recently established Health Technology Expert Review Panel. The Panel is an advisory body, convened to develop guidance and recommendations to CADTH on non-drug health technologies such as medical devices. The Panel consists of Core Members, who are appointed to serve for all topics under consideration, and Expert Members, who are appointed on a per-project basis, providing expertise on specific topics.